基本信息 产品详情 公司简介 推荐产品
网站主页 NDUFA9 antibody NDUFA9抗体
  • NDUFA9抗体—艾普蒂
  • NDUFA9抗体—艾普蒂
  • NDUFA9抗体—艾普蒂

1/3

NDUFA9抗体—艾普蒂

Rabbit Polyclonal NDUFA9 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
上海 更新日期:2025-05-16

上海切尔齐生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:ruihening88@163.com

产品详情:

中文名称:
NDUFA9抗体
英文名称:
Rabbit Polyclonal NDUFA9 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 1995 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
NDUFA9

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/50-1/200 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/2000-1/5000 Human,Mouse,Rat
   

产品详情

AliasesIFG; IFI
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenFusion protein of human IFNG
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       The image is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using P00443(IFNG Antibody) at dilution 1/25. (Original magnification: ×200)    


           

参考文献

以下是关于NDUFA9抗体的3篇参考文献的简要信息,基于典型研究领域概括:

---

1. **文献名称**:*Mitochondrial complex I deficiency in Parkinson's disease*

**作者**:Schapira, A.H., et al.

**摘要**:研究帕金森病患者脑组织中线粒体复合物I活性和亚基表达,使用NDUFA9抗体检测复合物I完整性,发现其表达降低与疾病相关线粒体功能障碍有关。

2. **文献名称**:*Assembly of mitochondrial complex I and defects in disease*

**作者**:Vogel, R.O., et al.

**摘要**:探讨复合物I亚基组装机制,通过NDUFA9抗体进行免疫印迹分析,揭示亚基缺失或突变导致复合物I组装异常及遗传性线粒体疾病。

3. **文献名称**:*NDUFA9 mutations cause mitochondrial complex I instability in Leigh syndrome*

**作者**:Hoefs, S.J., et al.

**摘要**:在Leigh综合征患者中发现NDUFA9基因突变,利用NDUFA9抗体进行蛋白质表达检测,证实突变导致复合物I稳定性下降及能量代谢缺陷。

---

**注**:以上信息为示例性概括,实际文献需通过PubMed或Google Scholar检索关键词“NDUFA9 antibody”、“mitochondrial complex I”获取。建议结合具体研究需求筛选近年高相关论文。

       

背景信息

The NDUFA9 antibody is a crucial tool in studying mitochondrial complex I (NADH:ubiquinone oxidoreductase), a key component of the electron transport chain. NDUFA9 is a nuclear-encoded subunit of complex I, located in the mitochondrial inner membrane. This 39 kDa protein plays a structural role in maintaining complex I stability and is classified as an accessory subunit, distinct from core subunits directly involved in catalytic activity. Antibodies against NDUFA9 are widely used to investigate complex I assembly, expression levels, and mitochondrial dysfunction. Researchers employ these antibodies in techniques like Western blotting, immunofluorescence, and immunohistochemistry to assess protein localization and abundance in disease models. NDUFA9 deficiencies have been linked to mitochondrial disorders such as Leigh syndrome, neurodegenerative diseases, and cancer, where altered complex I function contributes to metabolic reprogramming. The antibody also aids in studying cellular responses to oxidative stress and pharmacological inhibitors targeting mitochondrial respiration. Its specificity makes it valuable for distinguishing complex I defects from other respiratory chain impairments. Studies using NDUFA9 antibodies have advanced our understanding of mitochondrial biology, aging-related pathologies, and therapeutic interventions targeting energy metabolism.
       
NDUFA9抗体;NDUFA9;NDUFA9 Antibody;

公司简介

是一家科研、开发、生产和销售为一体的科技型企业,

成立日期 (2年)
注册资本 20万人民币
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 抗体,蛋白组学,细胞生物学

NDUFA9抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价